Literature DB >> 14656167

Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications.

Thomas Zeller1, Ulrich Frank, Christian Müller, Karlheinz Bürgelin, Uwe Schwarzwälder, Lutz Sinn, Barbara Horn, Helmut Roskamm, Franz-Josef Neumann.   

Abstract

PURPOSE: To analyze the impact of technical improvements in stent devices and guiding catheters (e.g., reduced device diameter, increased flexibility) on the complication rates associated with percutaneous renal artery interventions.
METHODS: During a 5-year period (1997-2001), 268 consecutive patients (178 men; mean age 67+/-9 years) had 370 atherosclerotic renal artery stenoses (RAS) > or =70% treated with angioplasty/stenting in 320 procedures. The guiding catheter technique was used routinely until 2000; in 2001, a guiding sheath was used in 29% of cases. From 1997 to 2000, sealing devices were frequently used for sheath removal; during the last year, the sheaths were removed using the Femostop device.
RESULTS: In 320 interventions, 32 (10%) complications occurred, with a decreasing frequency during the last 2 years (1996/97: 13% [7/53]; 1998: 16% [9/57]; 1999: 15% [11/74]; 2000: 4% [3/70]; 2001: 3% [2/66]). There were 21 (6.6%) local complications, including 4 cases requiring permanent hemodialysis after the intervention and 11 (3.4%) access site complications. No procedure-related death occurred. During the study period, the average sheath diameter was reduced from 8.15+/-0.76 F to 6.15+/-0.63 F (p<0.05). Mean procedural time was reduced from 42+/-13 minutes to 23+/-11 minutes (p<0.05). The initial heparin dose was reduced from 10,000 to 5000 units.
CONCLUSIONS: In parallel with the use of more flexible catheters and premounted stents of lower profile, the complication rate of renal angioplasty/stenting of atherosclerotic RAS has been reduced significantly during a 5-year period.

Entities:  

Mesh:

Year:  2003        PMID: 14656167     DOI: 10.1177/152660280301000526

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  6 in total

1.  Fibromuscular Dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-06

2.  Experience of stenting for atherosclerotic renal artery stenosis in a cardiac catheterization laboratory: technical considerations and complications.

Authors:  Percy P Jokhi; Krishnan Ramanathan; Simon Walsh; Anthony Y Fung; Jacqueline Saw; Rebecca S Fox; Nadia Zalunardo; Christopher E Buller
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

Review 3.  To Stent or Not to Stent? Update on Revascularization for Atherosclerotic Renovascular Disease.

Authors:  Elias Noory; Kaji Sritharan; Thomas Zeller
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

4.  Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Sevda Korkut Bayındır; Gülsüm Nihal Çürük; Abdurrahman Oguzhan
Journal:  Pain Res Manag       Date:  2017-05-28       Impact factor: 3.037

5.  Renal artery stenosis.

Authors:  Thomas Zeller
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

6.  Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.

Authors:  Michael Müller; Carl-Ludwig Schönfeld; Tanja Grammer; Vera Krane; Christiane Drechsler; Bernd Genser; Thomas Kohnen; Christoph Wanner; Winfried März
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.